Potassium iodide/sodium bicarbonate/theobromine

Anti-SUMO2 small ubiquitin-like modifier 2, 100ul UN 1687 6.

Anti-SUMO2 small ubiquitin-like modifier 2, 25ul UN 1687 6.1

Anti-TAOK2 TAO kinase 2, 25ul UN 1687 6.1 PG2

Anti-TAOK3 TAO kinase 3, 25ul UN 1687 6.1 PG2

Immunogen Synthetic peptide directed towards the N terminal region of human TBK1 Biochem/physiol Actions The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm.

General description Hepatitis A virus cellular receptor 1 homolog (UniProt Q5QNS5: also known as HAVcr-1, Kidney injury molecule 1, KIM-1, T cell immunoglobulin and mucin domain-containing protein 1, T-cell immunoglobulin mucin receptor 1, T cell

An antiemetic compound that selectively antagonizes the human NK1 receptor (Kis = 3 and 454.1 nM for hNK1 and hNK3, respectively IC₅₀ = 0.09 nM for hNK1).

An antiemetic compound that selectively antagonizes the human NK1 receptor (Kis = 3 and 454.1 nM for hNK1 and hNK3, respectively IC₅₀ = 0.09 nM for hNK1).

An antiemetic compound that selectively antagonizes the human NK1 receptor (Kis = 3 and 454.1 nM for hNK1 and hNK3, respectively IC₅₀ = 0.09 nM for hNK1).

A cell-permeable dioxotetrahydroquinoxaline compound that mimics uridine monophosphate for affinity interaction at the Argonaute-2 (Ago2) Mid domain (K D = 126 &#181M) and effectively inhibits Ago2 cellular miRNA loading in acute promyelocytic

BAPTA, tetrapotassium salt.

BAPTA, tetrapotassium salt.